Medicilon Logo
|
search icon search icon language icon contact icon menu icon
Medicilon Logo
|
search icon close search icon language icon contact icon menu icon
CN
Contact Us
Close Button
Message
Back To Top
Online Message×
Click switch
Close Button
Medicilon Events
News and Events

Medicilon Events

Hot information:
Medicilon Appoints Dr. Liu Jian as President of Drug Discovery Division| Medicilon FTE services & FFS services - flexible and efficient cooperation model| Medicilon appeared at the 25th SAPA-NE Annual Conference
Sep 20,2023
Medicilon's Interview: See how Dr. Chen Chen from ABM Therapeutics crosses the blood-brain barrier
Shanghai Medicilon Inc. (Medicilon) has the honor to invite Dr. Chen Chen, Founder and Chairman of ABM Therapeutics, to discuss the unique technical advantages and R&D strategies of ABM Therapeutics in developing brain-targeted drugs, as well as the inner journey and profound insights.
More
Medicilon's Interview: See how Dr. Chen Chen from ABM Therapeutics crosses the blood-brain barrier
Aug 14,2023
Medicilon was selected into the SSE Science and Technology Innovation Board 100 Index, R&D intensity and revenue growth have been recognized
On August 7, 2023, the Shanghai Stock Exchange officially launched the SSE Science and Technology Innovation Board 100 Index. Shanghai Medicilon Inc. was selected as one of the SSE Science and Technology Innovation Board 100 Index.
More
Medicilon was selected into the SSE Science and Technology Innovation Board 100 Index, R&D intensity and revenue growth have been recognized
Jul 31,2023
Medicilon interview with Dr. Xin Dong - In the field of immunotherapy, where the fierce competition is in full swing, where does Neologics Bioscience come from?
Medicilon interviewed Dr. Xin Dong to get a glimpse of his profound insights in the field of immunotherapy, and "learn from the experience" to grow in the era of new drugs.
More
Medicilon interview with Dr. Xin Dong - In the field of immunotherapy, where the fierce competition is in full swing, where does Neologics Bioscience come from?
Jul 28,2023
Fosun Health Capital reached a cooperation agreement with Medicilon to explore innovative drug research and development together
On July 25, 2023, Fosun Health Capital established by Fosun Pharma(stock code:600196.SH), reached a strategic partnership with Medicilon(stock code: 688202.SH).
More
Fosun Health Capital reached a cooperation agreement with Medicilon to explore innovative drug research and development together
Jul 27,2023
The Medicilon DMPK team was praised again, and Dr. Yan Feng, CEO of Leading Tac Pharma, came to present the award
Dr. Yan Feng, CEO of Leading Tac Pharma, came to present the award the Medicilon DMPK team the "Best Partner Award" to express their gratitude and recognition.
More
The Medicilon DMPK team was praised again, and Dr. Yan Feng, CEO of Leading Tac Pharma, came to present the award
Jul 27,2023
Fudan University, School of Management "Science and Technology Entrepreneur Camp" entered Medicilon: "Hardcore Technology" as the background color, Adding "luster" to new drug research and development
On July 14, Professor Xiongwen Lu, Dean of the School of Management of Fudan University, led the professor group of Fudan School of Management and the students of the fifth phase of the Fudan Science and Technology Entrepreneur Camp into the Zhangjiang Park of Shanghai Medicilon Inc. (Medicilon) to conduct a site visit.
More
Fudan University, School of Management "Science and Technology Entrepreneur Camp" entered Medicilon: "Hardcore Technology" as the background color, Adding "luster" to new drug research and development
Jul 14,2023
Another honor! Medicilon won the "Top 50 Chinese Pharmaceutical R&D" in 2022-2023
The press conference released the most influential list of China's pharmaceutical industry in 2022-2023. Medicilon once again won the "Top 50 Chinese Pharmaceutical R&D" in 2022-2023 based on its comprehensive strength.
More
Another honor! Medicilon won the "Top 50 Chinese Pharmaceutical R&D" in 2022-2023
Jul 12,2023
Medicilon topped the "Top 10 Most Influential CRO Enterprises" in the 2023 China Biopharmaceutical Industry Value List
The 9th BIO-PHARM2023 and the 2023 China Biopharmaceutical Industry Value List Awards Ceremony were grandly opened in Suzhou. Medicilon was listed in the "Top 10 Most Influential CRO Enterprises".
More
Medicilon topped the "Top 10 Most Influential CRO Enterprises" in the 2023 China Biopharmaceutical Industry Value List
Jul 12,2023
Medicilon and EyeCure reached a strategic collaboration to facilitate the preclinical research and development of ophthalmic cell and gene drugs
Recently, Shanghai Medicilon Inc. (Medicilon) and EyeCure reached a strategic collaboration. The two parties will carry out comprehensive collaboration in the field of ophthalmic cell and gene therapy.
More
Medicilon and EyeCure reached a strategic collaboration to facilitate the preclinical research and development of ophthalmic cell and gene drugs
Jul 12,2023
Five times in a row! Medicilon was shortlisted in the "2022 China CXO Enterprises Top 20 List"
On June 27, the 2022 China Pharmaceutical Industry Top 100 Series List was released. Shanghai Medicilon Inc. was once again shortlisted in the "China CXO Enterprises Top 20 List".
More
Five times in a row!  Medicilon was shortlisted in the "2022 China CXO Enterprises Top 20 List"
Jul 12,2023
CRO joins with technical companies to promote the transformation of innovative drug research and development, Medicilon and SciMatchmaker reached a strategic collaboration
Recently, Shanghai Medicilon Inc. (Medicilon) and SciMatchmaker reached a strategic collaboration. The two parties have reached an agreement on collaboration in new drug research and development and resource sharing.
More
CRO joins with technical companies to promote the transformation of innovative drug research and development, Medicilon and SciMatchmaker reached a strategic collaboration
Jul 07,2023
Medicilon Appoints Dr. Liu Jian as President of Drug Discovery Division
Medicilon, a one-stop pharmaceutical preclinical R&D service platform CRO, recognizes the importance of drug discovery as the cornerstone of new drug innovation. Medicilon Appoints Dr. Liu Jian as President of Drug Discovery Division.
More
Medicilon Appoints Dr. Liu Jian as President of Drug Discovery Division